Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Miromatrix Medical Inc. (NASDAQ: MIRO) announced its participation in the H.C. Wainwright Annual Global Investment Conference scheduled for May 24, 2022. The company specializes in bioengineering transplantable organs to address organ shortages. Interested parties can access the presentation via webcast starting at 7 am ET on the conference date. Miromatrix focuses on developing human livers and kidneys using proprietary technology to improve patient lives.

Positive

• Participation in a notable investment conference can enhance company visibility.
• Focus on bioengineering transplantable organs addresses a critical healthcare need.

Negative

• None.

EDEN PRAIRIE, Minn., May 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced its participation in the H.C. Wainwright Annual Global Investment Conference on May 24th, 2022.

Miromatrix Medical’s management is scheduled to present at the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the webcast beginning Tuesday, May 24, 2022, at 7am ET, here.

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

FAQ

When is the H.C. Wainwright Annual Global Investment Conference for Miromatrix Medical?

Miromatrix Medical will participate in the H.C. Wainwright Annual Global Investment Conference on May 24, 2022.

What is Miromatrix Medical's main technology focus?

Miromatrix Medical focuses on bioengineering fully transplantable human organs, primarily livers and kidneys.

How can I access Miromatrix Medical's presentation at the conference?

You can access the webcast of Miromatrix Medical's presentation beginning at 7 am ET on May 24, 2022.

What is the stock symbol for Miromatrix Medical?

The stock symbol for Miromatrix Medical is MIRO.